iBio Inc Stock Price, Latest News, Company Profile & Institutional Holding

#ThinkSabio Latest News

iBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio

Light
Dark